Lmr Partners LLP Amgen Inc Transaction History

Lmr Partners LLP

$10.2 Billion
Q2 2024

A detailed history of Lmr Partners LLP transactions in Amgen Inc stock. As of the latest transaction made, Lmr Partners LLP holds 232 shares of AMGN stock, worth $73,312. This represents 0.0% of its overall portfolio holdings.

Number of Shares

232

Previous 10,000 97.68%

Holding current value

$73,312

Previous $2.84 Million 97.47%

% of portfolio

0.0%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $60,958 - $74,079	232 New	232 $72,000
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $8.87 Million - $10.5 Million	41,415 Added 1413.96%	44,344 $9.85 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $661,338 - $806,060	2,929 New	2,929 $708,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $1.15 Million - $1.29 Million	5,106 New	5,106 $1.15 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $2.26 Million - $2.58 Million	-11,356 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $1.92 Million - $2.25 Million	9,027 Added 387.59%	11,356 $2.42 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $192,703 - $213,790	-825 Reduced 26.16%	2,329 $568,000
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $205,932 - $239,980	928 Added 41.69%	3,154 $785,000
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $105,160 - $125,227	-486 Reduced 17.92%	2,226 $512,000
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $636,370 - $707,696	2,712 New	2,712 $689,000
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $3.59 Million - $4.61 Million	-18,951 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $3.3 Million - $3.95 Million	18,951 New	18,951 $3.67 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $2.39 Million - $2.8 Million	-14,335 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $1.43 Million - $1.61 Million	7,888 Added 122.35%	14,335 $2.72 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $1.15 Million - $1.34 Million	6,447 New	6,447 $1.26 Million
Q2 2018 Aug 03, 2018	SELL	$166.05 - $186.51 $905,138 - $1.02 Million	-5,451 Closed	0 $0
Q4 2017 Jan 30, 2018	BUY	$168.79 - $188.59 $920,074 - $1.03 Million	5,451	5,451 $948,000

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Account